Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 269,480 | 173,688 | 134,126 | 122,722 | 106,698 |
| Receivables | 179,127 | 183,119 | 195,402 | 197,505 | 166,345 |
| Inventories | 32,895 | 46,501 | 64,652 | 77,769 | 80,146 |
| TOTAL | $498,300 | $419,989 | $405,216 | $409,774 | $363,638 |
| Non-Current Assets | |||||
| PPE Net | 18,879 | 19,521 | 19,744 | 19,965 | 20,202 |
| Intangibles | 663,859 | 701,163 | 739,841 | 777,393 | 826,311 |
| Other Non-Current Assets | 33,261 | 33,458 | 36,139 | 38,442 | 35,990 |
| TOTAL | $715,999 | $754,142 | $795,724 | $835,800 | $882,503 |
| Total Assets | $1,214,299 | $1,174,131 | $1,200,940 | $1,245,574 | $1,246,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 183,333 | 162,500 | 141,667 | 120,833 | 100,000 |
| Accounts payable and accrued liabilities | 2,992 | 3,494 | 7,637 | 6,627 | 3,851 |
| Accrued Expenses | 225,335 | 266,620 | 264,014 | 286,423 | 268,544 |
| TOTAL | $412,702 | $433,726 | $414,497 | $415,094 | $373,573 |
| Non-Current Liabilities | |||||
| Long Term Debt | 353,769 | 397,578 | 441,258 | 484,853 | 528,390 |
| Other Non-Current Liabilities | 268,095 | 147,985 | 147,991 | 148,015 | 148,102 |
| TOTAL | $621,864 | $545,563 | $589,249 | $632,868 | $676,492 |
| Total Liabilities | $1,034,566 | $979,289 | $1,003,746 | $1,047,962 | $1,050,065 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,595 | 34,067 | 33,572 | 34,126 | 33,973 |
| Common Shares | 38 | 37 | 37 | 37 | 36 |
| Retained earnings | -298,770 | -281,344 | -274,145 | -274,602 | -269,411 |
| Other shareholders' equity | 76 | 76 | -283 | 139 | 139 |
| TOTAL | $179,733 | $194,842 | $197,194 | $197,612 | $196,076 |
| Total Liabilities And Equity | $1,214,299 | $1,174,131 | $1,200,940 | $1,245,574 | $1,246,141 |